Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2001;88:727-732
Published online before print March 30, 2001, doi: 10.1161/hh0701.088512
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
88/7/727    most recent
hh0701.088512v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hamanaka, I.
Right arrow Articles by Nakao, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hamanaka, I.
Right arrow Articles by Nakao, K.
Related Collections
Right arrow Cell signalling/signal transduction
Right arrow Growth factors/cytokines
(Circulation Research. 2001;88:727.)
© 2001 American Heart Association, Inc.


Integrative Physiology

Induction of JAB/SOCS-1/SSI-1 and CIS3/SOCS-3/SSI-3 Is Involved in gp130 Resistance in Cardiovascular System in Rat Treated With Cardiotrophin-1 In Vivo

Ichiro Hamanaka, Yoshihiko Saito, Hideo Yasukawa, Ichiro Kishimoto, Koichiro Kuwahara, Yoshihiro Miyamoto, Masaki Harada, Emiko Ogawa, Noboru Kajiyama, Nobuki Takahashi, Takehiko Izumi, Rika Kawakami, Izuru Masuda, Akihiko Yoshimura, Kazuwa Nakao

From the Department of Medicine and Clinical Science (I.H., Y.S., I.K., K.K., Y.M., M.H., E.O., N.K., N.T., T.I., R.K., I.M., K.N.), Kyoto University Graduate School of Medicine, Kyoto, and Department of Molecular Genetics (H.Y., A.Y.), Institute of Life Science, Kurume University, Fukuoka, Japan.

Correspondence to Yoshihiko Saito, MD, Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto, Japan, 606-8507. E-mail yssaito{at}kuhp.kyoto-u.ac.jp

Abstract—CIS (cytokine-inducible SH2 protein), SOCS (suppressor of cytokine signaling), or SSI (signal transducers and activators of transcription [STAT]-induced STAT inhibitor) proteins are a family of cytokine-inducible negative regulators of cytokine signaling via Janus kinase (JAK)-STAT pathways. Given the evidence that the JAK-STAT pathway plays a critical role in the cardiovascular system, the primary objective of this study was to assess the effects of the CIS family on JAK-STAT signaling in the cardiovascular system in rats treated with cardiotrophin-1 (CT-1), an interleukin-6 family of cytokines. Intravenous injection of 20 µg/kg body weight of CT-1 induced a transient, marked increase in STAT3 activation in various tissues, including heart and lung, and subsequent upregulation of 2 members of the CIS family, JAK-binding protein (JAB)/SOCS-1/SSI-1 and CIS3/SOCS-3/SSI-3, in the same tissues. It was also observed that CIS3 was directly associated with JAK2 in vivo. Pretreatment with the same dose of CT-1 60 minutes before significantly attenuated the STAT3 activation induced by a second injection of CT-1. We previously reported that intravenous injection of CT-1 results in the nitric oxide (NO)-dependent hypotension accompanied by the induction of inducible NO synthase mRNA. In rats pretreated with CT-1, the induction of inducible NO synthase mRNA or hypotension by subsequent CT-1 injection was not observed. Forced expression of JAB or CIS3, but not other CISs, directly blocked CT-1–induced STAT3 activation in 293 cells. These results suggest that JAB and CIS3 serve as endogenous inhibitors of CT-1–mediated JAK-STAT signaling in the cardiovascular system in vivo.


Key Words: CIS family • JAB/SOCS-1/SSI-1 • cardiotrophin-1 • JAK-STAT signaling




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
D. H. Freed, R. H. Cunnington, A. L. Dangerfield, J. S. Sutton, and I. M.C. Dixon
Emerging evidence for the role of cardiotrophin-1 in cardiac repair in the infarcted heart
Cardiovasc Res, March 1, 2005; 65(4): 782 - 792.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
E. K. Podewski, D. Hilfiker-Kleiner, A. Hilfiker, H. Morawietz, A. Lichtenberg, K. C. Wollert, and H. Drexler
Alterations in Janus Kinase (JAK)-Signal Transducers and Activators of Transcription (STAT) Signaling in Patients With End-Stage Dilated Cardiomyopathy
Circulation, February 18, 2003; 107(6): 798 - 802.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. M Smith, S. Lecour, and M. N Sack
Innate immunity and cardiac preconditioning: a putative intrinsic cardioprotective program
Cardiovasc Res, August 15, 2002; 55(3): 474 - 482.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Hortner, U. Nielsch, L. M. Mayr, J. A. Johnston, P. C. Heinrich, and S. Haan
Suppressor of Cytokine Signaling-3 Is Recruited to the Activated Granulocyte-Colony Stimulating Factor Receptor and Modulates its Signal Transduction
J. Immunol., August 1, 2002; 169(3): 1219 - 1227.
[Abstract] [Full Text] [PDF]